Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2002 | 07-2002 | 04-2002 | 01-2002 | 10-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 779 | N/A | -3,238 | -2,206 | -1,039 |
| Depreciation Amortization | 48 | N/A | 152 | 103 | 52 |
| Accounts receivable | 880 | N/A | 2,206 | 989 | 2,468 |
| Other Working Capital | 179 | N/A | 1,336 | 46 | 2,008 |
| Other Operating Activity | -2,412 | 0 | -1,555 | -407 | -2,425 |
| Operating Cash Flow | $-526 | $N/A | $-1,100 | $-1,475 | $1,063 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8 | N/A | 2,168 | 2,181 | -537 |
| PPE Investments | -14 | N/A | -47 | -26 | -1 |
| Purchase Of Investment | N/A | N/A | -100 | -344 | -271 |
| Other Investing Activity | 200 | 0 | -358 | -27 | 0 |
| Investing Cash Flow | $178 | $N/A | $1,663 | $1,784 | $-809 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 750 | N/A | 224 | 224 | 224 |
| End Cash Position | 403 | N/A | 788 | 534 | 479 |
| Net Cash Flow | $-348 | $N/A | $563 | $309 | $255 |
| Free Cash Flow | |||||
| Operating Cash Flow | -526 | N/A | -1,100 | -1,475 | 1,063 |
| Capital Expenditure | -14 | N/A | -47 | -26 | -1 |
| Free Cash Flow | -540 | 0 | -1,147 | -1,501 | 1,063 |